Skip to navigation Skip to main content
  • Services
    • Services overview
    • Biodistribution
    • Shedding
    • Pharmacokinetics
    • Pharmacodynamics
    • Gene expression analysis
    • Biomarker discovery and validation
    • Pharmacogenomics
    • Plasma protein biomarker analysis
    • Immune monitoring services
  • Technologies
    • Technologies overview
    • qPCR
    • dPCR
    • Short RNA PCR
    • RNA and DNA extraction
    • Method development and validation
    • RNA-Seq
    • DNA-Seq
    • TCR sequencing
    • BCR sequencing
    • Olink proteomics
    • Illumina protein prep
  • Resources
  • About us
    • About us
    • Our team
    • Careers
    • Press releases
  • Products
Request a quote
Talk to us
Scientist working with advanced technologies such as qPCR, dPCR, and next-generation sequencing to identify reliable biomarkers and support translational research.
08 Sep
TATAA blog

Genomic biomarkers

Posted by author-avatar TaTaa Admin
September 8, 2025
Introducing genomic biomarker analysis A biomarker is an objectively measurable factor that can indicate disease risk, predict treat...
Continue reading
Illustration of a medical syringe representing siRNA-based advanced therapies for targeted gene silencing.
05 Sep
TATAA blog

qPCR, dPCR, and NGS for siRNA bioanalysis

Posted by author-avatar TaTaa Admin
September 5, 2025
Quantitative PCR (qPCR), digital PCR (dPCR), and Next-Generation Sequencing (NGS) are essential technologies in siRNA bioanalysis. They...
Continue reading
Sterile vials prepared for use in advanced therapy development and bioanalysis.
03 Sep
TATAA blog

Precision bioanalysis for advanced therapies

Posted by author-avatar TaTaa Admin
September 3, 2025
Method development and validation of regulatory qPCR and dPCR assays for biodistribution, viral shedding, and pharmacokinetics in gene ...
Continue reading
Comprehensive_Safety_Testing_in_CAR-T_Using_TCR-BCR_Sequencing_Olink_and qPCR-dPCR Illustration of CAR-T safety testing combining TCR/BCR sequencing, Olink proteomics, and qPCR/dPCR for comprehensive monitoring.
01 Sep
TATAA blog

TCR/BCR sequencing and dPCR for CAR-T safety monitoring

Posted by author-avatar TaTaa Admin
September 1, 2025
Immunosequencing entails the high-throughput sequencing of T-cell (TCR) and B-cell receptors (BCR), offering invaluable insights into t...
Continue reading
Illustration of blood sample collection for RNA extraction using PAXgene tubes.
22 Aug
TATAA blog

RNA extraction from PAXgene tubes

Posted by author-avatar TaTaa Admin
September 1, 2025
Controlling and optimizing steps in extracting RNA from PAXgene tubes significantly improves yield and quality and can lead to more acc...
Continue reading
Scientist analyzing digital PCR results for replication competent lentivirus detection in a high-throughput lab environment
08 Aug
TATAA blog

Replication competent lentivirus testing

Posted by author-avatar TaTaa Admin
September 9, 2025
Ensuring biosafety in cell therapies: Replication Competent Lentivirus Testing (RCL) with digital PCR Why Replication Competent Lentiv...
Continue reading
Oligonucleotide therapeutics targeting a long non-coding RNA (IncRNA). Antisense oligonucleotide (ASO) or small interfering RNA (siRNA) binds to a lncRNA strand, leading to its degradation or functional inhibition.
22 May
TATAA blog

IncRNA: From junk to a therapeutic goldmine

Posted by author-avatar TaTaa Admin
May 26, 2025
Not long ago, much of the genome that doesn’t encode proteins was dismissed as junk DNA. But science has made it abundantly clear that ...
Continue reading
Viral vector characterization and vector integrity assessment using molecular techniques for gene therapy quality control.
07 May
TATAA blog

Viral Vector Characterization and Integrity Testing

Posted by author-avatar TaTaa Admin
May 8, 2025
Viral vector characterization is the comprehensive analytical process used to evaluate the quality, identity, purity, potency, and safe...
Continue reading
Vector copy number (VCN) analysis using qPCR and dPCR for cell and gene therapy applications.
07 May
TATAA blog

Vector Copy Number Analysis

Posted by author-avatar TaTaa Admin
August 28, 2025
Balancing efficacy and safety through VCN analysis Vector copy number is all about balancing efficacy against safety. More copies will...
Continue reading
Optimal qPCR primer design for specific and efficient amplification in bioanalytical assays.
07 May
TATAA blog

qPCR Primer Design

Posted by author-avatar TaTaa Admin
May 8, 2025
This guide discusses strategies for designing qPCR assays, including primers and probes, for bioanalysis in cell and gene therapies.qPC...
Continue reading
  • 1
  • 2
  • Services
  • Technologies
  • Resources
  • About us
  • Products
  • Contact
  • Terms and condition
  • Privacy policy
Sign up to our newsletter

"*" indicates required fields

Copyright © 2026 TATAA Biocenter AB. All rights reserved​​.
Web design: Adapt Online.
Close
  • Home
  • Services
    • Biodistribution
    • Shedding
    • Pharmacokinetics
    • Pharmacodynamics
    • Gene expression analysis
    • Biomarker discovery and validation
    • Pharmacogenomics
    • Plasma protein biomarker analysis
    • Immune monitoring services
  • Technologies
    • qPCR
    • dPCR
    • Short RNA PCR
    • RNA and DNA extraction
    • Method development and validation
    • RNA-Seq
    • DNA-Seq
    • TCR sequencing
    • BCR sequencing
    • Olink proteomics
    • Illumina protein prep
  • Resources
  • About us
    • Our team
    • Careers
    • Press releases
  • Products
  • Request a quote
  • Talk to us